Version 2.78

Part Descriptions

LP14839-2   Plasmodium falciparum
Four species of the Plasmodium protozoa are considered true parasites of humans as they use humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Malaria today is usually restricted to tropical and subtropical areas and altitudes below 1,500 m., although in the past malaria was endemic in much of North America, Europe and even parts of northern Asia, and today is still present on the Korean peninsula. However, this present distribution could be affected by climatic changes and population movements. P. falciparum is the most prevalent species and responsible for the most morbidity and mortality worldwide. Early detect is of paramount importance due to the incidence of cerebral malaria and drug resistance. Malarial infections caused by P. falciparum are the most likely to progress to severe, potentially fatal forms with central nervous system involvement (cerebral malaria), acute renal failure, severe anemia, or acute respiratory distress syndrome.[CDC] Source: Regenstrief LOINC, CDC

LP20149-8   Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness. Source: NMS labs

Fully-Specified Name

Component
Plasmodium falciparum Ab.IgM
Property
Titr
Time
Pt
System
Ser
Scale
SemiQn
Method
IF

Additional Names

Short Name
P falciparum IgM Titr Ser IF
Display Name
P. falciparum IgM IF (S) [Titer]
Consumer Name Alpha Get Info
Plasmodium falciparum IgM antibody, Blood

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.24
Last Updated
Version 2.75
Order vs. Observation
Both

Member of these Groups Get Info

LOINC Group Group Name
LG41640-0 Plasmodium

Language Variants Get Info

Tag Language Translation
de-DE German (Germany) Plasmodium falciparum Ak.IgM:Titer:Zeitpunkt:Serum:Semiquantitativ:Immunfluoreszenztest
es-ES Spanish (Spain) Plasmodium falciparum IgM:Titulo / Factor de dilución:Punto temporal:Suero:Semicuantitativo:Inmunofluorescencia (IF)
Synonyms: Semicuantitativo
es-MX Spanish (Mexico) Plasmodium falciparum Ab.IgM:Título:Punto temporal:Suero:Cuantitativo:Inmunofluorescencia (IF)
fr-CA French (Canada) Plasmodium falciparum, IgM:Titre:Temps ponctuel:Sérum:SemiQn:Immunofluorescence
fr-FR French (France) Plasmodium falciparum Ac IgM:Titre:Ponctuel:Sérum:Semi-Quantitatif:Immunofluorescence
it-IT Italian (Italy) Plasmodium falciparum Ab.IgM:Titr:Pt:Siero:SemiQn:IF
Synonyms: Anticorpi IgM anticorpo Immunofluorescenza (IF) Microbiologia Punto nel tempo (episodio) Siero Titolo
nl-NL Dutch (Netherlands) Plasmodium falciparum As.IgM:titer:moment:serum:semikwantitatief:immunofluorescentie
Synonyms: antistof; antilichaam IF
pl-PL Polish (Poland) Plasmodium falciparum Ab.IgM:miano:punkt w czasie:surowica:półilościowy:immunofluorescencja
Synonyms: IgM Plasmodium falciparum Przeciwciała do Plasmodium falciparum Przeciwciała IgM do Plasmodium falciparum
pt-BR Portuguese (Brazil) Plasmodium falciparum Ac.IgM:Título:Pt:Soro:Qn:Imunofluorescência
Synonyms: ; P falciparum; Immune globulin M; Immunoglobulin M; Dilution factor; Titer; Titre; Ttr; Titered; Point in time; Random; Serum; SR; Quantitative; QNT; Quant; Quan; ACIF; FA; Fluorescent antibody; Immune fluorescence; Fluoresent; Immunoflour; Immunofluor; Immunofluorescence; IFA; Time Resolved Fluorescence; Anticomplement Immunofluorescence; TRF; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Acy; Anti; Malarial; Malaria; Microbiology
zh-CN Chinese (China) 恶性疟原虫 抗体.IgM:滴定度:时间点:血清:半定量型:免疫荧光法
Synonyms: Ab.IgM;IgM;抗体 IgM Ab;自身抗体 IFA法;IF法;抗补体免疫荧光法;时间分辨荧光法;荧光原位杂交技术;荧光原位杂交法;荧光抗体 免疫球蛋白 M 原形体 原质团 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 恶性疟;热带疟原虫 恶性疟原虫 Ab 效价;滴定浓度;滴定率;滴定量;滴度;稀释倍数;稀释因子;稀释系数 时刻;随机;随意;瞬间 疟 疟原虫 疟疾 疟病 瘴气

Example Units

Unit Source
{titer} Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=51842-3